The randomized ACCESS-TAVI study led by PD Dr. Tobias Rheude and DZHK-Prof. Michael Joner from the German Heart Center Munich ...

The Saudi Arabia Hemostasis Valves Market is experiencing significant growth owing to various factors such as advancements in healthcare infrastructure, rising prevalence of cardiovascular diseases, ...

Ahead of schedule and budget” was the catchphrase for the ribbon-cutting ceremony at Werfen’s opening of their new expanded ...

The global hemostasis testing systems market is poised for substantial growth, with a projected value surge from USD 2,149.3 million in 2023 to USD 3,666 million by 2033. This anticipated expansion is ...

The approved of Vistaseal has been expanded to include use in pediatric patients as an adjunct to hemostasis for mild to moderate bleeding.

Werfen today announced the opening of a new building, expanding its capabilities for innovation in Specialized Diagnostics, at its Hemostasis and Acute Care Diagnostics Technology Center, in Bedford, ...

Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V., ...

Olympus’s RDI™ technology and EndoClot ® PHS may give both physicians and patients peace of mind during and after endoscopic procedures. If an emergency bleed occurs in the ASC setting, physicians can ...